MIT-202-SE2

Organization name

Mitelos Bioscience S.L.

SRN

ES-MF-000001421

Manufacturer status

Active

7 warnings recorded — scroll inside the panel to see all entries.

• CW275

  If you are pregnant or breastfeeding, ask your doctor or pharmacist for advice before using OTIBLOCK®. There is no experience regarding the use of OTIBLOCK® during pregnancy and breastfeeding. Therefore, OTIBLOCK® should not be used if you are pregnant or breastfeeding unless recommended by your doctor.
• CW010

  Please, read these instructions for use carefully before you start using this product. Keep them, you may need to read them again.
• CW007

  Do not use if package is damaged
• CW135

  Keep out of reach of children.
• CW296

  Do not swallow. In case of poisoning, contact the National Toxicology Service.
• CW300

  In case of contact with eyes, rinse immediately with plenty of water.
• CW262

  Single patient multiple use

Primary placement in Sweden; available across 2 countries total.

Trade name

not provided

UDI-DI code

08437017221470

Basic UDI-DI

8437017221OTIBLOCK45

Reference / catalog number

MIT-202-SE2

Issuing entity

GS1

Risk category

Class IIa

Applicable legislation

MDR [Regulation (EU) 2017/745 on medical devices]

Status

On the market

Quantity

1

Additional product description

—

Additional information URL

No additional information URL provided by the manufacturer.

Clinical sizes

No clinical sizes registered for this device.

European Medical Device Nomenclature — the EU product classification assigned to this device.

• Q030499OTOLOGY DEVICES - OTHER

Certificate health across this manufacturer's portfolio.